Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

…, K Hanami, N Sawamukai, K Nakano… - Annals of the …, 2015 - ard.bmj.com
Objectives To investigate the possibility of discontinuing adalimumab (ADA) for 1 year
without flaring (DAS28-erythrocyte sedimentation rate (ESR) ≥3.2), and to identify factors …

Dopamine induces IL-6–dependent IL-17 production via D1-like receptor on CD4 naive T cells and D1-like receptor antagonist SCH-23390 inhibits cartilage …

K Nakano, K Yamaoka, K Hanami, K Saito… - The Journal of …, 2011 - journals.aai.org
A major neurotransmitter dopamine transmits signals via five different seven-transmembrane
G protein-coupled receptors termed D1–D5. Several studies have shown that dopamine …

Peripheral immunophenotyping identifies three subgroups based on T cell heterogeneity in lupus patients

…, K Sakata, K Nakano, K Hanami… - Arthritis & …, 2017 - Wiley Online Library
Objective To elucidate the diversity of systemic lupus erythematosus (SLE) based on
immunophenotyping. Methods Peripheral blood mononuclear cells were obtained from 143 SLE …

Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study)

…, K Hanami, N Yunoue, K Saito, K Amano… - Modern …, 2011 - Taylor & Francis
… Yunoue 4 K. Saito The First Department of Internal Medicine, School of Medicine, University
of … Nakamura I, Omata Y, Naito M, Ito K. Blockade of interleukin 6 signaling induces marked …

Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease

…, S Tsujimura, M Nawata, K Hanami… - Modern …, 2011 - academic.oup.com
It is often difficult to manage refractory gastrointestinal tract complications of Behçet’s
disease (entero-BD) by conventional therapy. In this study, we assessed the short- and long-term …

Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients—REACTION 52-week study

…, Y Kaneko, S Fukuyo, T Kurasawa, K Hanami… - …, 2011 - academic.oup.com
Objectives. To evaluate the effectiveness and safety of tocilizumab in RA patients in clinical
practice. Methods. We observed 232 consecutive RA patients who began tocilizumab in …

Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus

…, N Ohkubo, S Nakayamada, K Nakano, K Hanami… - Lupus, 2018 - journals.sagepub.com
Objective We examined the efficacy and safety of rituximab in patients with refractory
systemic lupus erythematosus (SLE). Methods The study enrolled 63 SLE patients who were …

Natural Antibiotic Function of a Human Gastric Mucin Against Helicobacter pylori Infection

M Kawakubo, Y Ito, Y Okimura, M Kobayashi, K Sakura… - Science, 2004 - science.org
Helicobacter pylori infects the stomachs of nearly a half the human population, yet most
infected individuals remain asymptomatic, which suggests that there is a host defense against …

[HTML][HTML] Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis

…, K Hanami, A Nawata, M Zhang, K Yamagata… - Arthritis Research & …, 2018 - Springer
Background Dermatomyositis (DM) with rapidly progressive interstitial lung disease (DM RP-ILD)
is a life-threatening condition. Serum cytokine levels are potentially suitable …

Phenotypic changes of lymphocytes in patients with systemic lupus erythematosus who are in longterm remission after B cell depletion therapy with rituximab

…, K Yamaoka, M Nawata, S Yukawa, K Hanami… - The Journal of …, 2011 - jrheum.org
Objective. Rituximab has recently emerged as a novel treatment strategy for systemic lupus
erythematosus (SLE). We investigated longitudinally the differentiation and phenotypic …